Related references
Note: Only part of the references are listed.Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial
Samuel P. Costello et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
Floris Imhann et al.
GUT (2018)
Oral corticosteroid exposure and adverse effects in asthmatic patients
Patrick W. Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report
Hong-Gang Wang et al.
MEDICINE (2018)
Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation
Zhao-Hua Shen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Does the Internet promote the unregulated use of fecal microbiota transplantation: a potential public health issue?
Jonathan Philip Segal et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2018)
Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients
David J. Nusbaum et al.
FEMS MICROBIOLOGY ECOLOGY (2018)
SHORT DURATION, LOW INTENSITY, POOLED FECAL MICROBIOTA TRANSPLANTATION INDUCES REMISSION IN PATIENTS WITH MILD-MODERATELY ACTIVE ULCERATIVE COLITIS: A RANDOMISED CONTROLLED TRIAL
Samuel P. Costello et al.
GASTROENTEROLOGY (2017)
Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis
Neeraj Narula et al.
INFLAMMATORY BOWEL DISEASES (2017)
Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation
Susana Fuentes et al.
ISME JOURNAL (2017)
Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial
Nikhil Pai et al.
BMJ OPEN (2017)
Fecal Microbiota Transplantation in Inflammatory Bowel Disease
Walter Reinisch
DIGESTIVE DISEASES (2017)
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection A Randomized Clinical Trial
Christine H. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail
B. Pigneur et al.
MUCOSAL IMMUNOLOGY (2016)
On the criteria used for assessing the risk of bias in randomized trials included in systematic reviews and meta-analyses addressing adverse effects
Stefanos Bonovas et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Donor Recruitment for Fecal Microbiota Transplantation
Sudarshan Paramsothy et al.
INFLAMMATORY BOWEL DISEASES (2015)
OP003. Faecal microbiota transplantation in Ulcerative Colitis: A randomised controlled trial
Journal of Crohns & Colitis (2015)
Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Dana Berg et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
The gut microbiota and inflammatory bowel disease
Katsuyoshi Matsuoka et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic et al.
GASTROENTEROLOGY (2014)
Ulcerative Colitis: Epidemiology, Diagnosis, and Management
Joseph D. Feuerstein et al.
MAYO CLINIC PROCEEDINGS (2014)
Canadian Association of Gastroenterology position statement: Fecal microbiota transplant therapy
Paul Moayyedi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
Nabeel Khan et al.
GASTROENTEROLOGY (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Impact of probiotics on colonic microflora in patients with colitis: A prospective double blind randomised crossover study
Jamil Ahmed et al.
INTERNATIONAL JOURNAL OF SURGERY (2013)
GRADE guidelines: 8. Rating the quality of evidence-indirectness
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
Antonio Tursi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Immunosuppressive Effects via Human Intestinal Dendritic Cells of Probiotic Bacteria and Steroids in the Treatment of Acute Ulcerative Colitis
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2010)
Stress Coping, Distress, and Health Perceptions in Inflammatory Bowel Disease and Community Controls
Lesley A. Graff et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Effect of a Probiotic Preparation (VSL# 3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis
Erasmo Miele et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis
Ajit Sood et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation
Isaac Soo et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis
PDR Higgins et al.
GUT (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials
M Oremus et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2001)
Share Paper
